Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-002194
Filing Date
2021-02-04
Accepted
2021-02-04 17:07:49
Documents
2
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 9892
2 POWER OF ATTORNEY poa_gordon.htm EX-24.1 7561
  Complete submission text file 0001567619-21-002194.txt   18817
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 21592095

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations